Department of Growth and Reproduction, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
The International Research and Research Training Centre in Endocrine Disruption of Male Reproduction and Child Health, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
JAMA Pediatr. 2020 Apr 1;174(4):e195881. doi: 10.1001/jamapediatrics.2019.5881. Epub 2020 Apr 6.
The initial clinical sign of pubertal onset in girls is breast gland development (thelarche). Although numerous studies have used recalled age at menarche (first menstruation) to assess secular trends of pubertal timing, no systematic review has been conducted of secular trends of thelarche.
To systematically evaluate published data on pubertal timing based on age at thelarche and evaluate the change in pubertal onset in healthy girls around the world.
A systematic literature search was performed in PubMed and Embase of all original peer-reviewed articles published in English before June 20, 2019.
Included studies used clinical assessment of breast development in healthy girls and used adequate statistical methods, including the reporting of SEs or CIs. The quality of the articles was evaluated by assessing study design, potential sources of bias, main characteristics of the study population, and methods of statistical analysis.
In accordance with PRISMA guidelines, all articles were assessed for eligibility independently by 2 authors. Weighted regression analysis was performed using a random-effects model.
Studies examining age at thelarche (development of Tanner breast stage 2) in healthy girls.
The literature search resulted in a total of 3602 studies, of which 30 studies fulfilled the eligibility criteria. There was a secular trend in ages at thelarche according to race/ethnicity and geography. Overall, the age at thelarche decreased 0.24 years (95% CI, -0.44 to -0.04) (almost 3 months) per decade from 1977 to 2013 (P = .02).
The age at thelarche has decreased a mean of almost 3 months per decade from 1977 to 2013. A younger age at pubertal onset may change current diagnostic decision-making. The medical community needs current and relevant data to redefine "precocious puberty," because the traditional definition may be outdated, at least in some regions of the world.
女孩青春期开始的最初临床标志是乳腺发育(乳房发育)。尽管许多研究都使用回忆起的初潮年龄(第一次月经)来评估青春期时间的长期趋势,但尚未对乳房发育的长期趋势进行系统评估。
系统评估基于乳房发育年龄的青春期时间的已发表数据,并评估世界各地健康女孩青春期开始的变化。
在 PubMed 和 Embase 中进行了系统的文献搜索,检索了截至 2019 年 6 月 20 日之前以英文发表的所有原始同行评审文章。
纳入的研究使用了对健康女孩乳房发育的临床评估,并使用了足够的统计方法,包括报告 SE 或 CI。通过评估研究设计、潜在的偏倚来源、研究人群的主要特征以及统计分析方法,对文章的质量进行了评估。
根据 PRISMA 指南,由两名作者独立评估所有文章的合格性。使用随机效应模型进行加权回归分析。
研究了健康女孩的乳房发育年龄(Tanner 乳房发育阶段 2)。
文献搜索共产生了 3602 项研究,其中 30 项研究符合入选标准。根据种族/民族和地理位置,乳房发育年龄存在长期趋势。总体而言,从 1977 年到 2013 年,乳房发育年龄每十年减少 0.24 岁(95%CI,-0.44 至-0.04)(几乎 3 个月)(P = .02)。
从 1977 年到 2013 年,乳房发育年龄平均每十年减少近 3 个月。青春期开始的年龄较小可能会改变当前的诊断决策。医学界需要当前和相关的数据来重新定义“性早熟”,因为传统的定义可能已经过时,至少在世界上的一些地区是这样。